Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 3 Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00654758
What this trial is testing

A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
AbbVie 33
Testing effectiveness (Phase 2)Study completedNCT01554943
What this trial is testing

Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients

Who this might be right for
Breast Cancer
Jules Bordet Institute 73
Large-scale testing (Phase 3)Active Not RecruitingNCT03711032
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

Who this might be right for
High-risk Non-muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC 1,397
Not applicableStudy completedNCT00827333
What this trial is testing

Palliative Care Teaching Sessions for Family Caregivers of Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
City of Hope Medical Center 372
Large-scale testing (Phase 3)Study completedNCT00322452
What this trial is testing

First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 1,329
Testing effectiveness (Phase 2)Ended earlyNCT00589238
What this trial is testing

Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 16
Large-scale testing (Phase 3)UnknownNCT04426955
What this trial is testing

Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Jiangsu HengRui Medicine Co., Ltd. 396
Testing effectiveness (Phase 2)Study completedNCT00295932
What this trial is testing

Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 79
Testing effectiveness (Phase 2)Study completedNCT00470184
What this trial is testing

Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer

Who this might be right for
Esophageal Cancer
Roswell Park Cancer Institute 41
Early research (Phase 1)WithdrawnNCT03607955
What this trial is testing

Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Cancer
Washington University School of Medicine
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699721
What this trial is testing

Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IINon-small Cell Lung Cancer Stage ⅢANon-small Cell Lung Cancer Stage IIIB
Xiangya Hospital of Central South University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02858921
What this trial is testing

Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma

Who this might be right for
Melanoma
Melanoma Institute Australia 60
Large-scale testing (Phase 3)Looking for participantsNCT05838716
What this trial is testing

Vitamin D for Prostate Endocrine Therapy

Who this might be right for
Stage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+1 more
University of Rochester 240
Testing effectiveness (Phase 2)Study completedNCT00423852
What this trial is testing

Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+2 more
Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT01816971
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
University of Chicago 76
Not applicableStudy completedNCT04529564
What this trial is testing

Real-world Data on Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy in Asia Area (PACIFIC AA)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 106
Testing effectiveness (Phase 2)Study completedNCT00629616
What this trial is testing

Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer

Who this might be right for
Breast Cancer
UNICANCER 116
Large-scale testing (Phase 3)UnknownNCT00303784
What this trial is testing

Prostate Adenocarcinoma TransCutaneous Hormones

Who this might be right for
AnemiaCardiovascular ComplicationsHot Flashes+2 more
University College, London 2,200
Early research (Phase 1)Study completedNCT00254384
What this trial is testing

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IA Lung Non-Small Cell Carcinoma AJCC v7Stage IB Lung Non-Small Cell Carcinoma AJCC v7+4 more
M.D. Anderson Cancer Center 50
Large-scale testing (Phase 3)Study completedNCT05323734
What this trial is testing

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

Who this might be right for
Tuberous Sclerosis Complex
Marinus Pharmaceuticals 129
Next Page